BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Global Biodefense - ECPv6.17.5.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Global Biodefense
X-ORIGINAL-URL:https://globalbiodefense.com
X-WR-CALDESC:Events for Global Biodefense
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20200308T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20201101T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20210314T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20211107T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20220313T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20221106T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20230312T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20231105T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:Asia/Singapore
BEGIN:STANDARD
TZOFFSETFROM:+0800
TZOFFSETTO:+0800
TZNAME:+08
DTSTART:20200101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:America/Los_Angeles
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20200308T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20201101T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20210314T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20211107T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20220313T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20221106T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20230312T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20231105T090000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:Europe/London
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20200329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20201025T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20210328T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20211031T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20220327T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20221030T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:Europe/Lisbon
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:WEST
DTSTART:20210328T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:WET
DTSTART:20211031T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:WEST
DTSTART:20220327T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:WET
DTSTART:20221030T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:WEST
DTSTART:20230326T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:WET
DTSTART:20231029T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:America/Chicago
BEGIN:DAYLIGHT
TZOFFSETFROM:-0600
TZOFFSETTO:-0500
TZNAME:CDT
DTSTART:20210314T080000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0500
TZOFFSETTO:-0600
TZNAME:CST
DTSTART:20211107T070000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0600
TZOFFSETTO:-0500
TZNAME:CDT
DTSTART:20220313T080000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0500
TZOFFSETTO:-0600
TZNAME:CST
DTSTART:20221106T070000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0600
TZOFFSETTO:-0500
TZNAME:CDT
DTSTART:20230312T080000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0500
TZOFFSETTO:-0600
TZNAME:CST
DTSTART:20231105T070000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20211108T120000
DTEND;TZID=America/New_York:20211108T150000
DTSTAMP:20210925T002112Z
CREATED:20210925T002112Z
LAST-MODIFIED:20210925T002112Z
UID:49797-1636372800-1636383600@globalbiodefense.com
SUMMARY:Impact of and Response to the Pandemic: Webinar 1
DESCRIPTION:The COVID-19 pandemic has illuminated and exacerbated challenges in caring for people of all ages with serious illness. The response to many of these challenges involved rapid innovation and as such provides valuable lessons learned that will likely significantly alter the field of serious illness care in the post-pandemic era. The Roundtable on Quality Care for People with Serious Illness will host a virtual workshop to provide a neutral venue for stakeholders in serious illness care to consider the lessons learned from the pandemic in order to continually improve care for people with serious illness in the future. \nThe virtual workshop will be held over three webinars in November. \n\n8 Nov  12:00 – 3:00PM: Impact of and Response to the Pandemic: Webinar 1\n18 Nov 12:00 – 3:00PM: Recovery and Resilience: Webinar 2\n30 Nov 1:00 – 3:30PM: Prevention and Preparedness: Webinar 3\n\n\nDescription\n\n\n\nA planning committee of the National Academies of Sciences\, Engineering\, and Medicine will organize and host a 1.5-day public workshop to examine the impact of the COVID-19 pandemic on serious illness care and consider lessons learned and future directions\, with specific focus on health care access\, health equity\, and innovative responses to care in the context of  the pandemic. \nThe workshop will feature invited presentations and panel discussions on topics that may include: \nDelivery of person-centered\, family-oriented care \n\nKey role of palliative care teams during the pandemic\nRole of caregivers and impact on caregivers’ physical\, emotional and mental health\nSpecific learnings from different care models in various care settings (e.g.\, hospital-based palliative care\, care at home\, and in the community)\nUse of telehealth and impact on access to care\n\nClinician-Patient-Family communication and advance care planning \n\nUse of technology to connect family members to patients\nUse of serious illness communication guides to train non-palliative care specialist health care professionals\n\nProfessional education and development \n\nUse of technology support and remote applications to quickly train health care professionals\nCollaboration between palliative care teams and ICU/Emergency Department staff\n\nPolicies and payment systems \n\nTelehealth supported by flexibility in payment\nThe need for better alignment between health care and social care\n\nPublic education and engagement \n\nHow to communicate effectively and engage the public in advance care planning\nAddressing grief/bereavement on large scale in the U.S.\n\nThe planning committee will develop the agenda for the workshop\, select speakers and discussants\, and moderate the discussions. A proceedings of the presentations and discussions at the workshop will be prepared by a designated rapporteur in accordance with institutional guidelines. \n\n\nPlease visit NASEM’s Caring for People with Serious Illness during the COVID-19 Pandemic: A Workshop on Lessons Learned and Future Directions site for more information.
URL:https://globalbiodefense.com/event/impact-of-and-response-to-the-pandemic-webinar-1/
CATEGORIES:Conference,Webinar-Webcast
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20211111
DTEND;VALUE=DATE:20211114
DTSTAMP:20210226T211932Z
CREATED:20210226T211804Z
LAST-MODIFIED:20210226T211932Z
UID:48685-1636588800-1636847999@globalbiodefense.com
SUMMARY:APCCMI 2021 - Asia Pacific Congress of Clinical Microbiology and Infection
DESCRIPTION:The APCCMI 2021 Asia Pacific Congress of Clinical Microbiology and Infection will take place 11-13 November 2021 in Singapore and through virtual offerings. \nAPCCMI is the biennial conference for the Asia Pacific Society of Clinical Microbiology and Infection (APSCMI). \nHighlighted topics include: \n\nMERS CoV\, avian influenza and other respiratory viruses\nTransplant infectious diseases\nAdvances in rapid diagnostics\nAdvances in influenza therapeutics\nOne Health in infectious diseases\nMalaria and vector borne infections\nHot topics in antimicrobial stewardship\nTuberculosis and mycobacteria\nUtility of genome sequencing\nClinical implications of microbiome\n\nWho should attend? \nInfectious disease doctors\, trainees and scientists\nClinical and laboratory microbiologists\nInfection control professionals including doctors\, nurses and epidemiologists\nOutbreak control professionals including doctors\, epidemiologists and policy makers\nPharmacists and pharmacologists\nScientists and students undertaking research in the related fields\nVaccine professionals including doctors\, nurses\, pharmacists and policy makers \nPlease visit the APCCMI 2021 website for more information.
URL:https://globalbiodefense.com/event/apccmi-2021-asia-pacific-congress-of-clinical-microbiology-and-infection/
LOCATION:Suntec Singapore Convention Centre\, 1 Raffles Boulevard\, Suntec City\, 039593\, Singapore
CATEGORIES:Conference
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20211112T083000
DTEND;TZID=America/New_York:20211112T133000
DTSTAMP:20211111T190139Z
CREATED:20211101T175106Z
LAST-MODIFIED:20211111T190139Z
UID:50918-1636705800-1636723800@globalbiodefense.com
SUMMARY:The Future of Malaria Research Symposium
DESCRIPTION:The Johns Hopkins Malaria Research Institute will host the 7th Future of Malaria Research Symposium on November 12\, prior to the American Society of Tropical Medicine and Hygiene’s annual meeting. \nStudents\, postdoctoral researchers\, and early career scientists are encouraged to submit an abstract to be considered for a short or long talk. Dr. Etienne Bilgo\, Postdoctoral Fellow in Biomedical Sciences at the Institut de Recherche en Science de la Santé-IRSS/Centre Muraz will deliver the keynote address. Organized by postdocs and students\, the event will be held via Zoom and scientists at all career levels are encouraged to attend. \nHighlighted topics include: \n\nVectorCAM: a low cost hand held tool for automated\, rapid morphological identification of mosquito species\nIdentification of a novel determinant associated with quinine resistance in a Plasmodium falciparum genetic cross\nModeling the emergence of piperaquine-resistant Plasmodium falciparum malaria in Africa\nMitochondrial multidrug resistant transporter (MDR6) and its interaction with the ISC pathway in Plasmodium falciparum\nInappropriate sales of antimalarials in private-sector drug shops in rural Uganda\nA modular cloning system for high efficiency production of Plasmodium falciparum transfection vectors\nEvaluating the effects of sorbitol synchronization of clinical isolates of Plasmodium falciparum on their susceptibility to antimalarial compounds\nComparison of overnight to early evening malaria vector collections in indoor setting in Nchelenge District\, Zambia\nNovel kinases play an essential role during asexual proliferation of Plasmodium falciparum parasites”\nImpacts of a 4.3kb structural variant on gene expression and insecticide resistance phenotype in the malaria vector An. funestus s.s.\nFactors associated with asymptomatic recurrences due to Plasmodium vivax infection after radical cure treatment in communities in the Peruvian Amazon\nOctopi: a ready-to-deploy high-throughput imaging solution for malaria management and malaria research\nDistinct antibody responses to Plasmodium antigens reveal candidate biomarkers of the intensity and timing of past exposure to malaria\nAn ex vivo model of oxidatively stressed red blood cells demonstrates a role for exogenous amino acids in enhancing bystander red blood cell function and morphology in malaria\nSystems analysis shows a role of cytophilic antibodies in shaping innate tolerance to malaria\nA Male-Drive Female-Sterile (MDFS) system in Anopheles gambiae targeting doublesex\nAssessing the use of microRNAs for the diagnosis of severe falciparum malaria\nPrevalence of Plasmodium falciparum submicroscopic infection and pregnancy outcomes in Congolese women at delivery\nUsing transgenic fungi to kill malaria mosquitoes\nConditional knockdown of essential proteins in P. falciparum Midgut Stages\nA semi-field system for quantitative tracking of Anopheles gambiae olfactory preferences\nEstimating the impact of RTS\,S deployment in areas with seasonal malaria chemoprevention\nTrends in falciparum malaria prevalence\, parasite density and associated risk factors in Akure\, Southwestern Nigeria: An implication for malaria elimination\nAssessing off-target effects of CRISPR-Cas9 based gene drives in Anopheles gambiae\nHeritable cultivable bacteria associated to wild Anopheles gambiae s.l. in Burkina Faso for paratransgenic control perspectives of malaria\n\nPlease visit the Johns Hopkins Bloomberg School of Public Health 7th Future of Malaria Research Symposium website for more information.
URL:https://globalbiodefense.com/event/the-future-of-malaria-research-symposium/
CATEGORIES:Conference,Webinar-Webcast
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20211116
DTEND;VALUE=DATE:20211118
DTSTAMP:20211111T211702Z
CREATED:20211101T201407Z
LAST-MODIFIED:20211111T211702Z
UID:50931-1637020800-1637193599@globalbiodefense.com
SUMMARY:Developing a Long-Term Strategy for Low-Dose Radiation Research in the U.S.
DESCRIPTION:This meeting hosted by the National Academies will focus on receiving information from the research community on low dose radiation research priorities and lessons to be learned from managing multidisciplinary programs. \n\nWhat are your views on research priorities for low dose radiation research?\nHow can epidemiology contribute to further understanding risks?\nMolecular approaches to improve understanding of DNA repair following low dose radiation exposures\nAdvancements in dosimetry to support radiation epidemiology\nEpigenetic changes and their applications to radiation epidemiology\nClonal hematopoiesis and space radiation\nTechniques used to identify functional elements of the microbiome\nOpportunities and challenges for epigenetics and microbiome research in low dose radiation exposures\nOverview of studies of in utero exposure to radiation with emphasis on low doses\nLimitations of low-dose epidemiological studies\nModeling radiation effects including radiation carcinogenesis\, normal tissue complications\, radioresistance and non-targeted effect\nMethods and tools to estimate radiation dose in low dose radiation studies of medical\, occupational\, and environmental exposures\nMethods to study immune response and its role in cancer development and treatment\nModern techniques for mapping cells carrying mutations in normal tissues\n\nPlease visit NASEM’s Developing a Long-Term Strategy for Low-Dose Radiation Research in the United States: Meeting 6\, November 16-17\, 2021 website for more information.
URL:https://globalbiodefense.com/event/developing-a-long-term-strategy-for-low-dose-radiation-research-in-the-u-s-2/
CATEGORIES:Conference,Webinar-Webcast
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20211116T090000
DTEND;TZID=America/New_York:20211116T160000
DTSTAMP:20211111T192222Z
CREATED:20211104T181912Z
LAST-MODIFIED:20211111T192222Z
UID:50927-1637053200-1637078400@globalbiodefense.com
SUMMARY:Enhanced Drug Distribution Security at the Package Level
DESCRIPTION:The FDA will hold a virtual public meeting on November 16\, 2021\, on enhanced drug distribution security at the package level. \nThe purpose of this public meeting is to provide members of the pharmaceutical distribution supply chain and other interested stakeholders an opportunity to provide input to FDA on the implementation of the enhanced drug distribution security provisions of the Drug Supply Chain Security Act (DSCSA) that go into effect in 2023. \nFDA requests that stakeholders prepare comments responding to the following questions for one or more of the topics listed below: \n\nHow is implementation of the 2023 enhanced system requirements progressing for your organization?\nWhat challenges is your organization facing?\nAre the proposed recommendations in FDA’s guidance on enhanced drug distribution security at the package level helpful to achieve compliance with 2023 enhanced system requirements? If not\, what additional information would be useful?\nAre there areas in which FDA could provide more clarity?\n\nTopics\n\nEnhanced Drug Distribution Security\n\nSystem Attributes\nAggregation\, Inference\, and Physical Security Features\n\n\nSystem Structure\n\nData Architecture\nAdoption of Data and System Security\nProtecting Confidential Commercial Information and Trade Secrets\nSystem Access and Data Retrieval\n\n\nEnhanced Product Tracing\n\nSerialized Transaction Information and Data Exchange (Incorporation of the Product Identifier into Product Tracing Information)\nResponsibilities of the Selling and Buying Trading Partners with regard to the Product Tracing Information\nHandling Aggregation Errors and Other Discrepancies\n\n\nGathering of Relevant Product Tracing Information\nEnhanced Verification\n\nVerification of Distributed Product\nVerification of Saleable Return Product\nAlerts for Illegitimate Product\n\n\nTrading Partner Readiness\n\nYour organization’s overall readiness for implementation\nComponents that your organization is furthest along in developing\, including the components being prioritized and the components that are easier or more challenging to implement\n\n\n\nAdditional Information\n\nEnhanced Drug Distribution Security at the Package Level Under the Drug Supply Chain Security Act Draft Guidance for Industry\nFDA Webinar on October 5\, 2021: Enhanced Drug Distribution Security in 2023 Under the DSCSA
URL:https://globalbiodefense.com/event/enhanced-drug-distribution-security-at-the-package-level/
CATEGORIES:Government Hosted,Webinar-Webcast
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20211117
DTEND;VALUE=DATE:20211122
DTSTAMP:20211111T191055Z
CREATED:20211102T180552Z
LAST-MODIFIED:20211111T191055Z
UID:50922-1637107200-1637539199@globalbiodefense.com
SUMMARY:ASTMH 2021 Annual Meeting
DESCRIPTION:The American Society for Tropical Medicine and Hygiene (ASTMH) will gather virtually from 17-21 November for the Annual Meeting of leaders and scientific experts invested in tropical medicine and global health. \nThe virtual gathering will feature a wide range of COVID-19 related work\, including reports on the potential protective effects of malaria\, new vaccine innovations and how pandemic safeguards have turned fevers into a dangerous stigma. Researchers also will present new findings on elimination efforts for a number of diseases\, such as leprosy and river blindness; probe whether a smartphone app can reveal a link between pandemic outdoor time and risks of tick-borne disease; and discuss potentially promising news on tamping down resurgent malaria\, including vaccine advances and progress against insecticide resistance. \nPlease visit the ASTMH 2021 Annual Meeting website for more information.
URL:https://globalbiodefense.com/event/astmh-2021-annual-meeting/
CATEGORIES:Conference,Webinar-Webcast
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20211118T120000
DTEND;TZID=America/New_York:20211118T150000
DTSTAMP:20210925T002459Z
CREATED:20210925T002459Z
LAST-MODIFIED:20210925T002459Z
UID:49800-1637236800-1637247600@globalbiodefense.com
SUMMARY:Recovery and Resilience: Webinar 2
DESCRIPTION:The COVID-19 pandemic has illuminated and exacerbated challenges in caring for people of all ages with serious illness. The response to many of these challenges involved rapid innovation and as such provides valuable lessons learned that will likely significantly alter the field of serious illness care in the post-pandemic era. The Roundtable on Quality Care for People with Serious Illness will host a virtual workshop to provide a neutral venue for stakeholders in serious illness care to consider the lessons learned from the pandemic in order to continually improve care for people with serious illness in the future. \nThe virtual workshop will be held over three webinars in November. \n\n8 Nov  12:00 – 3:00PM: Impact of and Response to the Pandemic: Webinar 1\n18 Nov 12:00 – 3:00PM: Recovery and Resilience: Webinar 2\n30 Nov 1:00 – 3:30PM: Prevention and Preparedness: Webinar 3\n\n\nDescription\n\n\n\nA planning committee of the National Academies of Sciences\, Engineering\, and Medicine will organize and host a 1.5-day public workshop to examine the impact of the COVID-19 pandemic on serious illness care and consider lessons learned and future directions\, with specific focus on health care access\, health equity\, and innovative responses to care in the context of  the pandemic. \nThe workshop will feature invited presentations and panel discussions on topics that may include: \nDelivery of person-centered\, family-oriented care \n\nKey role of palliative care teams during the pandemic\nRole of caregivers and impact on caregivers’ physical\, emotional and mental health\nSpecific learnings from different care models in various care settings (e.g.\, hospital-based palliative care\, care at home\, and in the community)\nUse of telehealth and impact on access to care\n\nClinician-Patient-Family communication and advance care planning \n\nUse of technology to connect family members to patients\nUse of serious illness communication guides to train non-palliative care specialist health care professionals\n\nProfessional education and development \n\nUse of technology support and remote applications to quickly train health care professionals\nCollaboration between palliative care teams and ICU/Emergency Department staff\n\nPolicies and payment systems \n\nTelehealth supported by flexibility in payment\nThe need for better alignment between health care and social care\n\nPublic education and engagement \n\nHow to communicate effectively and engage the public in advance care planning\nAddressing grief/bereavement on large scale in the U.S.\n\nThe planning committee will develop the agenda for the workshop\, select speakers and discussants\, and moderate the discussions. A proceedings of the presentations and discussions at the workshop will be prepared by a designated rapporteur in accordance with institutional guidelines. \n\n\nPlease visit NASEM’s Caring for People with Serious Illness during the COVID-19 Pandemic: A Workshop on Lessons Learned and Future Directions site for more information.
URL:https://globalbiodefense.com/event/recovery-and-resilience-webinar-2/
CATEGORIES:Conference,Webinar-Webcast
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20211130T090000
DTEND;TZID=America/New_York:20211130T170000
DTSTAMP:20211111T191610Z
CREATED:20211111T191610Z
LAST-MODIFIED:20211111T191610Z
UID:50925-1638262800-1638291600@globalbiodefense.com
SUMMARY:Antimicrobial Drugs Advisory Committee (AMDAC) Meeting
DESCRIPTION:The FDA Antimicrobial Drugs Advisory Committee (AMDAC) will convene on 30 November 2021 to discuss Merck and Ridgeback’s request for emergency use (EUA) of molnupiravir oral capsules for treatment of mild to moderate COVID-19 in adults who are at risk for progressing to severe COVID-19 and/or hospitalization. an investigational antiviral drug to treat COVID-19. \nFDA intends to make background material available to the public no later than two (2) business days before the meeting. \nBackground material and the link to the online teleconference meeting room will be available at 2021 Meeting Materials\, Antimicrobial Drugs Advisory Committee (formerly known as the Anti-Infective Drugs Advisory Committee. \nPublic Participation Information\nInterested persons may present data\, information\, or views\, orally or in writing\, on issues pending before the committee. \nFDA is establishing a docket for public comment on this meeting. The docket number is FDA-2021-N-0758. The docket will close on November 29\, 2021. Submit either electronic or written comments on this public meeting by November 29\, 2021. \nComments received on or before November 15\, 2021\, will be provided to the committee(s). Comments received after that date but by November 29\, 2021\, will be taken into consideration by FDA. \nLearn more at the FDA meeting announcement website. \n  \n 
URL:https://globalbiodefense.com/event/antimicrobial-drugs-advisory-committee-amdac-meeting/
CATEGORIES:Government Hosted
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20211130T130000
DTEND;TZID=America/New_York:20211130T153000
DTSTAMP:20210925T002821Z
CREATED:20210925T002750Z
LAST-MODIFIED:20210925T002821Z
UID:49802-1638277200-1638286200@globalbiodefense.com
SUMMARY:Prevention and Preparedness: Webinar 3
DESCRIPTION:The COVID-19 pandemic has illuminated and exacerbated challenges in caring for people of all ages with serious illness. The response to many of these challenges involved rapid innovation and as such provides valuable lessons learned that will likely significantly alter the field of serious illness care in the post-pandemic era. The Roundtable on Quality Care for People with Serious Illness will host a virtual workshop to provide a neutral venue for stakeholders in serious illness care to consider the lessons learned from the pandemic in order to continually improve care for people with serious illness in the future. \nThe virtual workshop will be held over three webinars in November. \n\n8 Nov  12:00 – 3:00PM: Impact of and Response to the Pandemic: Webinar 1\n18 Nov 12:00 – 3:00PM: Recovery and Resilience: Webinar 2\n30 Nov 1:00 – 3:30PM: Prevention and Preparedness: Webinar 3\n\n\nDescription\n\n\n\nA planning committee of the National Academies of Sciences\, Engineering\, and Medicine will organize and host a 1.5-day public workshop to examine the impact of the COVID-19 pandemic on serious illness care and consider lessons learned and future directions\, with specific focus on health care access\, health equity\, and innovative responses to care in the context of  the pandemic. \nThe workshop will feature invited presentations and panel discussions on topics that may include: \nDelivery of person-centered\, family-oriented care \n\nKey role of palliative care teams during the pandemic\nRole of caregivers and impact on caregivers’ physical\, emotional and mental health\nSpecific learnings from different care models in various care settings (e.g.\, hospital-based palliative care\, care at home\, and in the community)\nUse of telehealth and impact on access to care\n\nClinician-Patient-Family communication and advance care planning \n\nUse of technology to connect family members to patients\nUse of serious illness communication guides to train non-palliative care specialist health care professionals\n\nProfessional education and development \n\nUse of technology support and remote applications to quickly train health care professionals\nCollaboration between palliative care teams and ICU/Emergency Department staff\n\nPolicies and payment systems \n\nTelehealth supported by flexibility in payment\nThe need for better alignment between health care and social care\n\nPublic education and engagement \n\nHow to communicate effectively and engage the public in advance care planning\nAddressing grief/bereavement on large scale in the U.S.\n\nThe planning committee will develop the agenda for the workshop\, select speakers and discussants\, and moderate the discussions. A proceedings of the presentations and discussions at the workshop will be prepared by a designated rapporteur in accordance with institutional guidelines. \n\n\nPlease visit NASEM’s Caring for People with Serious Illness during the COVID-19 Pandemic: A Workshop on Lessons Learned and Future Directions site for more information.
URL:https://globalbiodefense.com/event/prevention-and-preparedness-webinar-3/
CATEGORIES:Conference,Webinar-Webcast
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20211203
DTEND;VALUE=DATE:20211204
DTSTAMP:20210226T214741Z
CREATED:20210226T214741Z
LAST-MODIFIED:20210226T214741Z
UID:48694-1638489600-1638575999@globalbiodefense.com
SUMMARY:One Health: Integrating Human\, Animal and Environmental Health
DESCRIPTION:A virtual science conference on One Health: Integrating Human\, Animal and Environmental Health will be held 3 December 2021. \nThe One Health movement\, which has come to prominence in the last decade\, advocates greater cross-sectoral collaboration and communication across the human-animal-environment interface. There has been a long-standing recognition that population health is intrinsically linked to both animal and environmental health\, and that issues such as population growth\, changes in climate and land use\, and the movement of animals and people\, have a huge impact on the collective health of our world today. \nPlease visit EMBL’s One Health: Integrating Human\, Animal and Environmental Health page for more information.
URL:https://globalbiodefense.com/event/one-health-integrating-human-animal-and-environmental-health/
CATEGORIES:Conference,Webinar-Webcast
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20211208T090000
DTEND;TZID=America/New_York:20211208T103000
DTSTAMP:20240623T192553Z
CREATED:20211005T192345Z
LAST-MODIFIED:20240623T192553Z
UID:50043-1638954000-1638959400@globalbiodefense.com
SUMMARY:Current Concepts in Quantitative Risk Assessment for Skin Sensitization
DESCRIPTION:The NTP Interagency Center for the Evaluation of Alternative Toxicological Methods (NICEATM) is partnering with the Swiss Centre for Applied Human Toxicology and the Swiss State Secretariat for Economic Affairs to present a webinar series on “Current Concepts in Quantitative Risk Assessment for Skin Sensitization.” \nThe next webinar in the series on December 8 will consider the topics of methods for skin sensitization hazard and potency determination using currently available non-animal test methods\, as well as exposure assessment and quantification. \nThe webinar series is free and open to the public. Those who registered to view the first webinar are automatically registered for the second webinar. \nInformation and a link to register are available at https://ntp.niehs.nih.gov/go/ssqra-web. A video from the first webinar in the series\, which presented an introduction to skin sensitization and contact dermatitis\, will be posted on this page when available. \nRegister for the December 8 webinar: “Methods for hazard and exposure assessment”
URL:https://globalbiodefense.com/event/current-concepts-in-quantitative-risk-assessment-for-skin-sensitization/
CATEGORIES:Conference,Government Hosted,Webinar-Webcast
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20211216
DTEND;VALUE=DATE:20211217
DTSTAMP:20211106T220805Z
CREATED:20211106T220727Z
LAST-MODIFIED:20211106T220805Z
UID:50876-1639612800-1639699199@globalbiodefense.com
SUMMARY:National Biodefense Science Board Meeting
DESCRIPTION:The National Biodefense Science Board (NBSB) will meet in public (virtually) on December 16\, 2021\, to provide advice and recommendations to ASPR regarding the development of the 2023-2026 National Health Security Strategy and to discuss other matters of current important for public health emergency preparedness\, response\, and recovery. \n\n\n\nA more detailed agenda will be available on the NBSB meeting website https://www.phe.gov/​nbsb. \n\n\n\nProcedures for Public Participation\n\n\n\nMembers of the public may attend the meeting via a toll-free phone number or Zoom teleconference\, which requires pre-registration. The meeting link to pre-register will be posted on the meeting website https://www.phe.gov/​nbsb. Members of the public may provide written comments or submit questions for consideration by the NBSB at any time via email to NBSB@hhs.gov. \nSource: Federal Register Notice
URL:https://globalbiodefense.com/event/national-biodefense-science-board-meeting/
CATEGORIES:Government Hosted,Webinar-Webcast
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20220114T103000
DTEND;TZID=America/New_York:20220114T173000
DTSTAMP:20211111T212345Z
CREATED:20211111T212345Z
LAST-MODIFIED:20211111T212345Z
UID:50933-1642156200-1642181400@globalbiodefense.com
SUMMARY:Lessons Learned from the COVID-19 Pandemic to Improve Diagnosis
DESCRIPTION:The National Academies of Sciences\, Engineering\, and Medicine will convene a virtual workshop on January 14\, 2022 to examine changes to diagnostic paradigms in response to the COVID-19 pandemic and to consider the lessons learned and opportunities for improving diagnosis within the U.S. health care system. \nThe workshop will be accessible to the public via live webcast. Please register online to receive an email with the instructions on how to join this workshop. \nPlanning Committee: \n\nDerek Angus\, (Co-chair)\, University of Pittsburgh\nAndrew Bindman (Co-chair)\, Kaiser Permanente\nAmesh Adalja\, Johns Hopkins Center for Health Security\nSuzanne Bakken\, Columbia University\nMarie-Carmelle Elie\, University of Alabama School of Medicine\nNicole Lurie\, Coalition for Epidemic Preparedness Innovations\nKathryn McDonald\, Johns Hopkins University\nKosali Simon\, Indiana University\nSaul Weingart\, Rhode Island Hospital and Brown University\n\nPlease visit NASEM’s Advancing Diagnostic Excellence: A Workshop Series website for more information. \n 
URL:https://globalbiodefense.com/event/lessons-learned-from-the-covid-19-pandemic-to-improve-diagnosis/
CATEGORIES:Webinar-Webcast,Workshop
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20220209
DTEND;VALUE=DATE:20220211
DTSTAMP:20211111T221529Z
CREATED:20211111T221529Z
LAST-MODIFIED:20211111T221529Z
UID:50938-1644364800-1644537599@globalbiodefense.com
SUMMARY:Animal Welfare Challenges in Research and Education on Wildlife\, Non-Model Animal Species and Biodiversity
DESCRIPTION:The National Academies will host a meeting 9-10 February 2022 to discuss the current understanding of animal welfare challenges in research on wildlife and biologically diverse vertebrate animal species.  \nResearch to advance understanding of the ecology and biology of wildlife species is more important than ever as the world confronts issues ranging from biodiversity loss to the emergence of zoonotic diseases. \nThis workshop will focus on issues associated with the unique welfare challenges of conducting research with biologically diverse vertebrates living in varied habitats\, for which guidance resources on wildlife research sometimes conflict and recommendations outlined in the current version of the Guide for the Care and Use of Laboratory Animals (8th edition) can present challenges. \nThe workshop will include presentations and panel discussions to explore topics and questions\, such as: \n\nUnderstanding the growing needs of\, and building strategies for\, enhancing veterinary and Institutional Animal Care and Use Committee (IACUC) expertise on the health and welfare of wildlife and biologically diverse vertebrate animal species;\nDiscuss resource options for improving the development and evaluation of IACUC protocols on research studies involving wildlife and biologically diverse vertebrate animal species interactions in captive and diverse natural environmental settings;\nDiscussing bioethics associated with fieldwork practices (e.g.\, bleeding\, euthanasia including thoracic compressions for small birds) and unique considerations for wildlife and biologically diverse vertebrate animal species; as well as welfare assessments amidst other considerations such as unique physiological\, behavioral\, environmental\, and/or husbandry needs of wildlife and biologically diverse vertebrate animal species;\nDiscussing federal\, state\, and local regulatory and management challenges associated with research on terrestrial and aquatic wildlife and biologically diverse vertebrate animal species;\nDiscussing opportunities for enhancing collaborations between IACUCs and researchers studying wildlife and biologically diverse vertebrate animal species\, including animal-environment interactions\, anthropogenic effects on environment and animal life\, and the relation between animal\, environmental\, and human health.\nDiscussing strategies\, synergies\, and collaborations within and among the wildlife and biologically diverse vertebrate animal research\, and biodiversity communities that could leverage national level research resources\, identify knowledge gaps\, and facilitate knowledge acquisition and sharing.\nReview the reasons and advantages for IACUC review of research using wildlife and biologically diverse vertebrate animal species\, including regulatory compliance\, public relations\, and institutional protection.\n\nPlease visit NASEM’s Animal Welfare Challenges in Research and Education on Wildlife\, Non-Model Animal Species and Biodiversity website for more information.
URL:https://globalbiodefense.com/event/animal-welfare-challenges-in-research-and-education-on-wildlife-non-model-animal-species-and-biodiversity/
CATEGORIES:Conference,Webinar-Webcast,Workshop
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20220307T133000
DTEND;TZID=America/New_York:20220307T150000
DTSTAMP:20220305T134424Z
CREATED:20220303T133528Z
LAST-MODIFIED:20220305T134424Z
UID:54171-1646659800-1646665200@globalbiodefense.com
SUMMARY:National Biodefense Science Board Public Meeting
DESCRIPTION:The next public meeting of the National Biodefense Science Board (NBSB) will take place Monday\, 7 March 2022 from 1:30pm – 3:00pm ET via Zoom. \nJoin federal leaders\, National Biodefense Science Board members\, distinguished guests\, and other experts to discuss topics related to the public health supply chain and climate change.  NBSB will hear from the HHS Office of Climate Change and Health Equity and Joint Program Executive Office for Chemical\, Biological\, Radiological\, and Nuclear Defense (JPEO-CBRND) during the meeting. \nSubject matter experts from industry; academia; health systems; health consumer organizations; state\, local\, tribal\, and territorial public health; and emergency management agencies will also have an opportunity to provide comments to the NBSB on national priorities for biodefense and health security. Individual remarks will be limited to seven minutes each and the display of images and/or slides for public speakers will not be available. \nRequests to provide remarks to the NBSB during the public meeting must be sent to NBSB@hhs.gov by March 4\, 2022. In that request\, please provide the speaker’s name\, title\, and position with a brief summary of planned comments. The number of speakers and topics will be based on relevance to the mission of the NBSB and amount of time available on the agenda.  Those selected for public comments will receive confirmation by email prior to the meeting date with additional instructions. \nRegistration for this event is required and can be accessed along with additional meeting information through the online event page.  We encourage you to share this engagement information broadly across your network in advance of the meeting. \nMeeting materials will be made available to the public on the National Biodefense Science Board webpage. For any additional information or questions specific to this event\, please contact NBSB@hhs.gov directly.
URL:https://globalbiodefense.com/event/national-biodefense-science-board-public-meeting-3/
CATEGORIES:Government Hosted,Webinar-Webcast
LOCATION:https://hhsasproea.zoomgov.com/webinar/register/WN_DdvW3yVpTuGWSIey8ZsfBg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20220322
DTEND;VALUE=DATE:20220325
DTSTAMP:20220225T203340Z
CREATED:20220225T203242Z
LAST-MODIFIED:20220225T203340Z
UID:54067-1647907200-1648166399@globalbiodefense.com
SUMMARY:ASPPH Annual Meeting 2022
DESCRIPTION:The Association of Schools and Programs of Public Health ASPPH Annual Meeting 2022 will be held online 22-24 March 2022. \nThe ASPPH Annual Meeting convenes academic public health leaders\, faculty\, students\, and members of the public health community from around the world for three days to engage in discussions and share new strategies and tools to strengthen education\, practice\, and research in public health. \nHighlighted topics include: \n\nEducation for Public Health in a Post-COVID World\nBuilding Trust in Public Health Emergency Preparedness and Response\nGlobal Governance for Health: The Role of Academic Public Health\nUsing ASPPH Data Resources for Academic Public Health Research\nUnderstanding and Responding to Health Misinformation and Disinformation\nThe Public Health Fulcrum: Convening for Multi-disciplinary and Interprofessional Education for Collaborative Practice\nUsing Digital Marketing for Engagement and Recruitment\nClimate Change and Health: The Defining Issue of Our Time\n\nPlease visit the ASPPH website for more information.
URL:https://globalbiodefense.com/event/aspph-annual-meeting-2022/
CATEGORIES:Conference
LOCATION:https://globalbiodefense.com/event/aspph-annual-meeting-2022/
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20220327
DTEND;VALUE=DATE:20220401
DTSTAMP:20220325T155530Z
CREATED:20220225T165130Z
LAST-MODIFIED:20220325T155530Z
UID:54584-1648339200-1648771199@globalbiodefense.com
SUMMARY:SOT 2022 - Society of Toxicology Annual Meeting
DESCRIPTION:The 61st Annual Meeting of the Society of Toxicology will be held 27-31 March 2022 in San Diego\, California with livestream options for remote participation. \nThis year’s meeting will include all the traditional hallmarks—2\,000+ scientific presentations across 70+ sessions; 250 exhibitors with products and services in the ToxExpo; and scores of networking and social events. This year’s meeting will also feature a key new element that will enhance the meeting experience for all. Registrants not traveling to the meeting can watch all the Featured and Scientific Sessions live through the SOT Event App or Online Planner. Of note\, all registrants can access these same sessions through on-demand recordings that will be available in the SOT Event App and Online Planner after their conclusion. These on-demand videos will be viewable to registrants through July 31\, 2022. \nHighlighted sessions of interest include: \n\nConceptual Models in Immunotoxicology: Leveraging Biological Knowledge\, Alternative Approaches\, and Computational Strategies for the Future of Risk Assessment\nAll for One and One for All: One Environmental Health in Toxicology\nMethodological Aspects of Vascular Toxicity\nPrinciples and Applications of Read-Across in Human Health Risk Assessment\nHow Advances in Exposure Science and Toxicology Are Changing Assessments of the Effects of Chemical Mixtures on Human Health\nLeading-Edge Microbiome Methods for Toxicological Applications\nApplications of Single Cell Profiling Methods to Enhance Mechanistic Understanding of Toxicological Responses\nNext-Level Neurotoxicology: New Technologies to Advance Visualization of Spatial Molecular Alterations and Behavioral Phenotyping\nComparative Toxicology\, Pathology\, and Veterinary Specialty Section Officers Meeting\nAssay Gaps in the Developmental Neurotoxicity (DNT) New Approach Methodologies (NAMs) Battery for Human Health Risk Assessment\nApplication of the devTOX quickPredict and Cardio quickPredict Biomarker-Based In Vitro Assays for Toxicity Screening: Presented by Stemina Biomarker Discovery\nBiotechnology\, Mechanisms\, Molecular and Systems Biology Joint Specialty Section Mentoring Event\nSimulated-Use Extractables: A Risk Mitigation Strategy for Medical Device Toxicological Risk Assessments (TRAs): Presented by WuXi AppTec – Laboratory Testing Division\nBad Breath: Noninvasive Investigation into the Exhaled Biomarkers for Toxicological Research\nUp to the Task? Quantitative Evaluation Criteria for Physiologically Based Pharmacokinetic (PBPK) Models\n\nPlease include the following National Toxicology Program (NTP) Interagency Center for the Evaluation of Alternative Toxicological Methods (NICEATM) and Interagency Coordinating Committee on the Validation of Alternative Methods (ICCVAM) activities in your itinerary for the first two days of the Society of Toxicology (SOT) 2022 annual meeting. A list of all NICEATM and ICCVAM activities is available here. For remote participants\, all times are Pacific Daylight Time. \nSunday\, March 27: Continuing Education Courses: \n\nAM02: Conceptual Models in Immunotoxicology: Leveraging Biological Knowledge\, Alternative Approaches\, and Computational Strategies for the Future of Risk Assessment (8:15 a.m.-12 noon): Acting NICEATM Director Nicole Kleinstreuer is a speaker.\nPM11: Next-Level Neurotoxicology: New Technologies to Advance Visualization of Spatial Molecular Alterations and Behavioral Phenotyping (1:15-5:00 p.m.): NICEATM scientist Helena Hogberg (National Institute of Environmental Health Sciences) is presenting.\n\nMonday\, March 28: Oral Presentation Sessions: \n\nSymposium Session: New Approach Methods for Functional Developmental Neurotoxicity (9:15 a.m.-12:00 noon – CC Ballroom 6E): ICCVAM advisory committee member Tamara Tal (Helmholtz Centre for Environmental Research) is session chair; Acting NICEATM Director Nicole Kleinstreuer is session co-chair.\nPlatform Session: Risk Assessment (9:15 a.m.-12:00 noon – CC Room 8): “Modification of the Skin Allergy Risk Assessment (SARA) Model for GHS Classification and Its Application to Isothiazolinone Case Studies\,” presented by NICEATM scientist Judy Strickland (Inotiv\, contractor supporting NICEATM).\n\nMonday\, March 28: Poster Sessions: \n\nPFAS I (9:00-10:45 a.m.)\nAutoimmunity/Hypersensitivity (2:30-4:15 p.m.)\nNeurotoxicity: General (2:30-4:15 p.m.)\nReproductive and Developmental Toxicology I (2:30-4:15 p.m.)\nFood Safety/Nutrition (2:30-4:15 p.m.)\n\nProof of COVID-19 vaccination is required to participate in the on-site meeting. \nPlease visit the SOT 2022 website to register and for more information. \n 
URL:https://globalbiodefense.com/event/sot-2022-society-of-toxicology-annual-meeting/
LOCATION:San Diego Convention Center\, 111 West Harbor Drive\, San Diego\, CA 92101\, 92101\, United States
CATEGORIES:Conference
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20220329
DTEND;VALUE=DATE:20220331
DTSTAMP:20220322T155748Z
CREATED:20220322T155748Z
LAST-MODIFIED:20220322T155748Z
UID:54522-1648512000-1648684799@globalbiodefense.com
SUMMARY:Building Public Trust in Public Health Emergency Preparedness and Response (PHEPR) Science
DESCRIPTION:The National Academies’ Planning Committee on Building Public Trust in Public Health Emergency Preparedness and Response (PHEPR) Science will hold a workshop on 29-30 March. \nWorkshop discussants and participants will collaboratively generate actionable strategies and approaches to (re)build and maintain trust across this continuum\, across stakeholders\, across levels of the system (federal\, state\, tribal\, territorial\, and local)\, and across emergency types. Workshop discussants and participants will specifically: \n\nExamine why the topic of public trust (and trustworthiness\, credibility\, confidence in\, among others) is important in PHEPR science and develop a shared understanding of its importance and its relationship to other factors that contribute to social cohesion in public health emergencies.\nExplore key elements of PHEPR science communication and generate actionable communications strategies based on recent experiences.\nGenerate actionable strategies and approaches for building/maintaining trust\, communicating PHEPR science and the scientific process in the face of uncertainty and in response to the recent decline in perceived credibility of federal\, state\, and local agencies.\nExamine the ways in which diverse demographic groups experience PHEPR science differently and generate strategies and approaches for building trust in PHEPR science and the scientific process that is tailored to these varied experiences.\n\nWorkshop Planning Committee members include: \n\nSandra Quinn\, Ph.D.\, M.Ed. (Chair)\, University of Maryland\nDominique Brossard\, Ph.D.\, University of Madison-Wisconsin\nEsther Chernak\, M.D.\, M.P.H.\, FACP\, Drexel University\nKenny Hendrickson\, Ph.D.\, University of the Virgin Islands\nHilary Karasz\, Ph.D.\, M.A.\, Public Health – Seattle and King County\nJennifer Kiger\, M.P.H.\, LSSBB\, Harris County Public Health\nRachael Piltch-Loeb\, Ph.D.\, M.S.P.H.\, Harvard University\nKai Ruggeri\, Ph.D.\, Columbia University\nMonica Schoch-Spana\, Ph.D.\, Johns Hopkins University\nCathy Slemp\, M.D.\, M.P.H.\, Catherine C Slemp\, LLC
URL:https://globalbiodefense.com/event/building-public-trust-in-public-health-emergency-preparedness-and-response-phepr-science/
CATEGORIES:Conference,Workshop
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20220330T130000
DTEND;TZID=America/New_York:20220330T153000
DTSTAMP:20220323T181737Z
CREATED:20220323T163049Z
LAST-MODIFIED:20220323T181737Z
UID:54546-1648645200-1648654200@globalbiodefense.com
SUMMARY:Inaugural Joint Meeting of NACSD and NACIDD
DESCRIPTION:Please join Assistant Secretary for Preparedness and Response Dawn O’Connell along with Assistant Secretary for Aging and Acting Administrator for Community Living Alison Barkoff\, Wednesday\, March 30 from 1:00 p.m. to 3:30 p.m. ET for the inaugural meeting of the National Advisory Committee on Seniors and Disasters (NACSD) and National Advisory Committee on Individuals with Disabilities and Disasters (NACIDD). \nAdvanced registration for this meeting is required and can be accessed\, along with additional meeting information\, through the online event page. \nDuring this joint meeting\, committee members will be sworn into service and begin a national discussion with federal subject matter experts on the challenges\, opportunities\, and priorities in meeting the unique health needs of older adult populations and people with disabilities during and after disasters and public health emergencies. \nThe agenda includes time to hear from the public. The floor will be open to hear as many relevant comments as possible. To learn how to request a speaking time\, please visit our event page. Meeting materials also will be made publicly available through that page. You can send questions about the NACSD to NACSD@hhs.gov and questions about the NACIDD to NACIDD@hhs.gov. \nBackground \nThe National Advisory Committee on Seniors and Disasters (NACSD) and the National Advisory Committee on Individuals With Disabilities and Disasters (NACIDD)\, or Committees\, were established by sections 2811B and 2811C\, respectively\, of the Public Health Service (PHS) Act\, as amended by the Pandemic and All Hazards Preparedness and Advancing Innovation Act (PAHPAIA) of 2019. The Committees are governed by the provisions of the Federal Advisory Committee Act (FACA) and the General Services Administration FACA Final Rule. The Committees evaluate issues and programs and provide findings\, advice\, and recommendations to the Secretary of HHS to support and enhance all-hazards public health and medical preparedness\, response\, and recovery. The NACSD provides focus on the unique needs of older adults\, while the NACIDD focuses on helping HHS meet the needs of people with disabilities (PWD). The Secretary of HHS has formally delegated authority to operate the NACSD and the NACIDD to ASPR. \nFor Further Information:\nDr. Maxine Kellman\, NACSD Designated Federal Official\, 202-260-0447\, NACSD@hhs.gov; Tabinda Burney\, NACIDD Designated Federal Official\, 202-699-1779\, NACIDD@hhs.gov. Office of the Assistant Secretary for Preparedness and Response (ASPR)\, Department of Health and Human Services (HHS)\, Washington\, DC. \nLearn more and register at the ASPR website \n 
URL:https://globalbiodefense.com/event/national-advisory-committee-on-seniors-and-disasters-nacsd-and-national-advisory-committee-on-individuals-with-disabilities-and-disasters-nacidd/
CATEGORIES:Conference,Government Hosted
ATTACH;FMTTYPE=image/jpeg:https://globalbiodefense.com/wp-content/uploads/2022/03/nacidd-individuals-disabilities-disasters-seniors-disasters-aspr.jpg
LOCATION:https://hhsasproea.zoomgov.com/webinar/register/WN_qCfSOHCWT4qTywRzWw_3fA
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20220404T110000
DTEND;TZID=America/New_York:20220404T170000
DTSTAMP:20220321T200058Z
CREATED:20220321T200058Z
LAST-MODIFIED:20220321T200058Z
UID:54494-1649070000-1649091600@globalbiodefense.com
SUMMARY:Public Workshop on Use of Population Descriptors in Genomics Research
DESCRIPTION:The second meeting of the Committee on Use of Race\, Ethnicity\, and Ancestry as Population Descriptors in Genomics Research will be held on April 4 and April 7\, 2022. \nAs part of this workshop\, the committee request public comment on the current use of population descriptors such as race\, ethnicity\, ancestry\, etc. in genomics research and how the use of population descriptors could be improved upon in the future. \nThe agenda will be available on the event webpage. \nThe committee requests public comments as part of this workshop. The committee would like to hear from researchers\, advocates\, and any other interested stakeholders on how population descriptors are currently being used effectively in genomics research\, how they could be improved\, and what systems might be used effectively in the future. \nThe committee will invite a few authors representing a sample of the submissions to present their comments at the workshop on April 4th. If you wish to be considered as a speaker at this workshop\, please submit your comment by March 23rd. Authors of submission submitted after March 23rd may also be considered to be speakers at the workshop in the summer. \nClick here to learn more and submit your comment.
URL:https://globalbiodefense.com/event/public-workshop-on-use-of-population-descriptors-in-genomics-research/
CATEGORIES:Conference
LOCATION:https://bit.ly/nasem-genomics
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20220404T130000
DTEND;TZID=America/New_York:20220404T140000
DTSTAMP:20220906T194716Z
CREATED:20220327T183107Z
LAST-MODIFIED:20220906T194716Z
UID:54592-1649077200-1649080800@globalbiodefense.com
SUMMARY:Deterring Russia's Biological\, Chemical and Nuclear Threat
DESCRIPTION:Biological\, Chemical\, and Nuclear Weapons: Can the West deter Russia from using them? \nThe National Committee on American Foreign Policy (NCAFP) will the event 4 April 2022 from 1:00 – 2:00 Eastern. \nOn February 27 President Vladimir Putin ordered Russia’s nuclear deterrent forces to be put on high alert\, sending shockwaves through Europe and the international community. As the conflict has drawn on longer than anticipated\, U.S. intelligence officials have warned of Putin’s “back against the wall” escalations. More recently\, on March 11th\, Russian propaganda outlets accused the U.S. of funding and harboring biological weapons facilities in Ukraine. Although these claims are false\, the Kremlin’s misinformation campaign has signaled to Russia-watchers and intelligence officials that Putin is fabricating information and messaging to justify his own intention to authorize chemical\, biological\, or a possible small tactical nuclear weapon. \nHow can the U.S.\, Europe Union\, and Allies brace for a possible Russian chemical or biological weapons attack in Ukraine? Are there lessons the U.S. has learned from the failure to respond to chemical weapons use in Syria in 2013? How might Western countries prevent\, mitigate\, or respond to such an attack? How could NATO\, the U.S.\, and Allies respond while trying to prevent further escalations? \nTo help answer these questions and many more\, please join the Honorable Andy Weber\, Senior Fellow at the Council on Strategic Risks’ and former Assistant Secretary of Defense for Nuclear\, Chemical and Biological Defense Programs\, and Mr. Ankit Panda\, Stanton Senior Fellow in the Nuclear Policy Program at Carnegie Endowment for International Peace. The program will be moderated by Ambassador (ret.) Susan M. Elliott\, President & CEO of the NCAFP. \nPlease visit the NCAFP’s Deterring Russia’s Biological\, Chemical and Nuclear Threat event page to register. \n 
URL:https://globalbiodefense.com/event/deterring-russias-biological-chemical-and-nuclear-threat/
CATEGORIES:Conference
LOCATION:https://us02web.zoom.us/webinar/register/WN_Sco1z-VkS5yuV4Zr-801Vw
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20220413T180000
DTEND;TZID=America/New_York:20220413T200000
DTSTAMP:20220323T224400Z
CREATED:20220323T224249Z
LAST-MODIFIED:20220323T224400Z
UID:54559-1649872800-1649880000@globalbiodefense.com
SUMMARY:Schar School Master's and Certificate Open House
DESCRIPTION:The George Mason University (GMU) Schar School of Policy and Government will host a Master’s and Certificate Open House on April 13\, 2022 from 6:00 pm – 8:00 pm in Arlington\, Virginia. \nThe event will provide an overview of available master’s degree programs and highlight GMU’s world-class faculty and research. Admissions and student services staff will be on hand to answer questions. \nThis in-person event is the perfect opportunity to: \n\nExplore our top-ranked master’s degree and graduate certificate programs\nMeet Schar School Dean Mark Rozell\, program directors\, current students\, alumni\, and admissions team\nVisit the Schar School\nLearn about your program of interest in depth\, including the curriculum\, admissions requirements\, and career opportunities\nAsk admissions team members specific questions about the application process\n\nHave your application fee waived  \nProspective master’s and graduate certificate students who attend this event will be provided with an application fee waiver for the Fall 2022 graduate application. \nRegister to attend here. \nGlobal Biodefense is an official media partner of the GMU Schar School Biodefense program.
URL:https://globalbiodefense.com/event/schar-school-masters-and-certificate-open-house/
LOCATION:George Mason University Arlington Campus\, 3351 Fairfax Dr\, Arlington\, VA\, 22201\, United States
CATEGORIES:Workshop
ATTACH;FMTTYPE=image/jpeg:https://globalbiodefense.com/wp-content/uploads/2022/03/220413-schar-school-open-house-large-banner-event.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20220418
DTEND;VALUE=DATE:20220520
DTSTAMP:20220323T164348Z
CREATED:20220323T164348Z
LAST-MODIFIED:20220323T164348Z
UID:54551-1650240000-1653004799@globalbiodefense.com
SUMMARY:ICE\, ICE\, Data: Using NICEATM’s Integrated Chemical Environment to Support Chemical Evaluations
DESCRIPTION:Join us April 18-19 for a special training session featuring experts from the NTP Interagency Center for the Evaluation of Alternative Toxicological Methods (NICEATM). \nNICEATM’s Integrated Chemical Environment is a free online suite that houses curated toxicity and physicochemical property data\, integrated into a variety of tools to analyze and visualize chemical data. These tools provide data access adhering to FAIR principles: data that is Findable\, Accessible\, Interoperable\, and Reusable for chemical characterization\, PBPK\, IVIVE\, and more! \nAt this two-day event\, you will learn directly from NICEATM developers how to use the Integrated Chemical Environment and have the opportunity to have your questions answered in the Q&A session. For your convenience\, a printable agenda is available for download below. You will receive session materials through the Zoom Webinar platform ahead of the event. Recordings and other materials will be made available shortly after the sessions. Registration is free\, but required to attend.
URL:https://globalbiodefense.com/event/ice-ice-data-using-niceatms-integrated-chemical-environment-to-support-chemical-evaluations/
CATEGORIES:Conference,Training
ATTACH;FMTTYPE=image/jpeg:https://globalbiodefense.com/wp-content/uploads/2022/03/NURA-ICE.jpg
LOCATION:https://us06web.zoom.us/webinar/register/WN_UK_LklHqT5iGGtBgCy_Cjg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20220423
DTEND;VALUE=DATE:20220427
DTSTAMP:20220421T013722Z
CREATED:20220420T234848Z
LAST-MODIFIED:20220421T013722Z
UID:54824-1650672000-1651017599@globalbiodefense.com
SUMMARY:32nd EECMID - European Congress of Clinical Microbiology & Infectious Diseases
DESCRIPTION:The 32nd European Congress of Clinical Microbiology & Infectious Disease (ECCMID) will take place as a hybrid event both online and in Lisbon\, Portugal on 23 – 26 April 2022. \nThe event brings together experts from many fields to present their latest findings\, guidelines and experiences to an audience of over 14\,000 colleagues. This year\, the congress will feature a hybrid format to facilitate an onsite and online experience for attendees allowing for remote and face-to-face opportunities to take part in the multifaceted programme. \nHighlighted programme topics include: \n\nAdvances in Clostridioides difficile infection outbreak prevention and control\nDigging in the molecular epidemiology of MDR Enterobacterales\nNovel insights into herpetic infections\nOpportunistic infections of the central nervous system\nFungal infections from head to toes\nPathogenic Escherichia coli: the emergence of cross pathotypes from the genomic continuum\nOne Health and mycology: what are the significant and potential interactions between agriculture and human health?\nLeveraging the host response to acute infection to create new diagnostic and prognostic tools\nNew insights into phages: current challenges and future developments\nHow to apply Digital PCR in clinical microbiology\nmRNA science: a paradigm shift to address unmet medical needs\nA post-COVID syndrome: a never-ending story\nPathogens and the microbiome: antibiotics at the crossroads\nRespiratory viral infections in hospital settings\nRole of monoclonal antibodies (mAbs) in the evolution of COVID-19 treatment\nNew perspectives on Schistosomiasis in Europe\nShould you manage bloodstream infection differently in immunocompromised patients?\nGenomics underpin the clinical and public health management of tuberculosis\nCOVID-19 diagnostics: new and newer\nNovel predictive and diagnostic tools in severe viral and bacterial infections\nModelling host-pathogen interaction in persistent infections\nRapid diagnostic tools inform prudent antibiotic use\n\nPlease visit the European Congress of Clinical Microbiology & Infectious Diseases 2022 meeting page to register.
URL:https://globalbiodefense.com/event/32nd-eecmid-european-congress-of-clinical-microbiology-infectious-diseases/
LOCATION:Congrex Switzerland\, Reinacherstrasse 131\, Basel\, CH-4053\, Switzerland
CATEGORIES:Conference
ORGANIZER;CN="European Society of Clinical Microbiology and Infectious Diseases (ESCMID)":MAILTO:info@escmid.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20220425T070000
DTEND;TZID=America/New_York:20220425T163000
DTSTAMP:20220422T174133Z
CREATED:20220422T174133Z
LAST-MODIFIED:20220422T174133Z
UID:54835-1650870000-1650904200@globalbiodefense.com
SUMMARY:Malaria in Africa: Translating Science Into Practice
DESCRIPTION:The Johns Hopkins Malaria Research Institute will host a World Malaria Day Symposium on 25 April 2022 featuring presentations by the five NIH International Centers of Excellence for Malaria Research (ICEMRs) that are actively working in Africa in the countries of Mali\, Uganda\, Ethiopia\, Kenya\, Malawi\, Mozambique\, Democratic Republic of Congo\, Zimbabwe\, and Zambia. \nCONFIRMED KEYNOTE SPEAKERS \n\nDr. Matshidiso Rebecca Moeti\, Regional Director for Africa\, World Health Organization\n“Science\, research and precision disease control with malaria as entry point”\nDr. Rick Steketee\, Deputy U.S. Global Malaria Coordinator\, U.S. President’s Malaria Initiative\n“Malaria science and program: challenging topics of climate and localization”\nProfessor Sheila Tlou\, ALMA Special Ambassador\, African Leaders Malaria Alliance\n“ALMAs 4-point agenda in the fight against malaria: linking policy\, accountability and action to science”\n\nThe Johns Hopkins Malaria Research Institute’s state-of-the-art facility is the hub for a community of multidisciplinary researchers dedicated to treat\, control and eradicate this deadly disease. Focused on four major areas of research: Entomology\, Parasitology\, Epidemiology and Immunology\, JHMRI boasts experts from around the globe\, all working to prevent and cure malaria. \nPlease visit the Johns Hopkins Malaria Research Institute World Malaria Day Symposium event page to register for the event
URL:https://globalbiodefense.com/event/malaria-in-africa-translating-science-into-practice/
CATEGORIES:Webinar-Webcast
ATTACH;FMTTYPE=image/png:https://globalbiodefense.com/wp-content/uploads/2022/04/world-malaria-day-johns-hopkins.png
LOCATION:https://jh.zoom.us/webinar/register/WN_KEnjPeZNT8OkDXaSNvYniA
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20220501
DTEND;VALUE=DATE:20220505
DTSTAMP:20220420T225637Z
CREATED:20210925T162254Z
LAST-MODIFIED:20220420T225637Z
UID:49837-1651363200-1651708799@globalbiodefense.com
SUMMARY:2022 ASM Clinical Virology Symposium
DESCRIPTION:The 2022 ASM Clinical Virology Symposium will be held 1-4 May 2022 in West Palm Beach\, Florida and with virtual participation options. \nThe event brings together top biomedical scientists\, physicians and laboratorians to discuss the latest in diagnostic virology\, vaccine development\, molecular diagnostics and more. \nASM will also include a virtual component providing access to the scientific program and accommodating those who are unable or do not wish to attend in-person. Get details on the digital experience. \nThe symposium is intended for physicians\, laboratory directors\, laboratory professionals\, technicians\, laboratory supervisors\, technologists and other health care professionals with an interest in the latest developments in clinical and diagnostic virology. \nHighlighted session topics include: \n\nMeasles Resurgence in the U.S. and Beyond\nHumoral and Cellular Immune Responses to SARS-CoV-2 After Natural Infection and Vaccination\nOpportunities and Challenges for Next Generation Sequencing of SARS-CoV-2\nLaboratory Stewardship of Diagnostic Tests within the Clinical Virology Laboratory\nTesting Trends and Guidelines for Screening and Monitoring of HIV Infections\nCRISPR/Cas Gene Editing as a Strategy for Antiviral Therapy: A Potential Cure for HIV-1\nA Physician’s Perspective on the Clinical Utility of Next Generation Sequencing\nCapacity Building Strategies in Dealing with a Global Outbreak of Viral Disease\nOutcome Studies to Evaluate the Clinical Impact of Laboratory Testing\nAssociation Between Enteroviruses and Acute Flaccid Myelitis\nGlobal Challenge of Emerging & Reemerging Viral Infections – A Report from the Tropics\nInfluenza During the COVID-19 Pandemic\nWastewater-based Epidemiology: Public Health Value of Tracking Existing and Emerging Viruses\nThe Quest for a Safe and Effective RSV Vaccine: Is It Nearly Within Reach?\nAn Update on Standardization and Harmonization of Molecular Diagnostics\n\nPlease visit the ASM Clinical Virology Symposium site for more information.
URL:https://globalbiodefense.com/event/2022-asm-clinical-virology-symposium/
CATEGORIES:Conference
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20220503
DTEND;VALUE=DATE:20220507
DTSTAMP:20220420T214323Z
CREATED:20220420T213804Z
LAST-MODIFIED:20220420T214323Z
UID:54802-1651536000-1651881599@globalbiodefense.com
SUMMARY:ABSA 2nd Biosecurity Symposium
DESCRIPTION:ABSA International will host the 2nd Biosecurity Hybrid Symposium 3-6 May 2022 in a hybrid virtual and in-person format in Minneapolis\, Minnesota. \nThe hybrid symposium will consist of papers\, presentations\, keynotes\, posters\, valuable networking opportunities\, and in-person exhibits. Attendees may register for the in-person event or the virtual event. \nThe event will gather biosecurity professionals from a wide range of disciplines with varying expertise to share their experiences and knowledge and to learn from each other. The agenda includes themes on biosecurity governance\, implementation\, personnel reliability\, bioeconomy\, biosecurity in DIYbio communities\, biosecurity training\, cyberbiosecurity\, and interactive discussions on lessons learned and public engagement for the future. \nThe symposium will showcase thought-provoking leaders and pioneering researchers from various traditional and non-traditional fields that intersect with biosecurity. A segment on new and emerging topics in biosecurity will also be featured. \nHighlighted sessions include: \n\nBiosecurity: Past\, Present\, and Future: Vibeke Halkjaer-Knudsen\, PhD\, Sandia National Laboratories\, Albuquerque\, NM\nEnhancing Security for Emerging Biotechnologies through Collaboratively Designed Exercises: Julie E. Fischer\, PhD\, CRDF Global\, Arlington\, VA\nPreventing Future Pandemics: The Critical Role of Biosecurity in Global Health Security: Samantha Dittrich\, PhD\, Merrick & Company\, Arlington\, VA\nEnhancing Biosecurity Globally Through Implementation of Personal Reliability Programs: Brittany Linkous\, MS\, Merrick & Company\, Arlington\, VA\nBiosecurity and the Bioeconomy: J. Bradley Dickerson\, PhD\, Sandia National Laboratories\, Albuquerque\, NM\nLab Design Matters: Maria Landron\, DrPH\, Association of Public Health Laboratories (APHL)\, Silver Spring\, MD\nTianjin Biosecurity Guidelines for Codes of Conduct for Scientists: Gigi Kwik Gronvall\, PhD\, Johns Hopkins Center for Health Security\, Baltimore\, MD\nConcentric by Ginkgo: Building a Biosecurity and Public Health Platform for the Present and Future: Brian Renda\, PhD\, Ginkgo Bioworks\, Boston\, MA\nRegional Legal Framework as a Basis and an Enhancer of Biosafety and Biosecurity in the African Union Member States: Jaures Arnaud Noumedem Kenfack\, Africa Centers for Diseases Control and Prevention\, Abuja\, Nigeria\nInfectious Disease as a Security Threat and the Role of Public Health Emergency Management in Biodefense and Biosecurity: A COVID-19 Case Study: Ryan S. Houser\, MS\, MPH\, Tetra Tech\, Parsippany\, NJ\nBiosecurity Capacity Building Through a Biosecurity Champions Fellowship Program in Pakistan: Samreen Sarwar\, M.Phil\, Health Security Partners\, Lahore\, Pakistan\nIdentifying and Avoiding Common Mistakes in Risk and Threat Management: Lauren Richardson\, DVM\, MPH\, Merrick and Company\, Arlington\, VA\nBeyond Training: Using Behavioral Science to Motivate Proactive Biorisk Management: Daniel Greene\, PhD\, Stanford University\, Stanford\, CA\nCommunity Driven Genome Engineering Biosecurity Workshop: Industry Practices\, Resources\, and Opportunities: Beth Vitalis\, Inscripta\, Boulder\, CO\n\nPlease visit ABSA International’s 2nd Biosecurity Symposium website to register.
URL:https://globalbiodefense.com/event/absa-2nd-biosecurity-symposium/
LOCATION:Renaissanc Minneapolis Hotel\, The Depot\, 225 3rd Ave S\, Minneapolis\, MN\, 55401-2524\, United States
CATEGORIES:Conference,Webinar-Webcast
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20220503T140000
DTEND;TZID=America/New_York:20220503T150000
DTSTAMP:20220420T201056Z
CREATED:20220420T200824Z
LAST-MODIFIED:20220420T201056Z
UID:54789-1651586400-1651590000@globalbiodefense.com
SUMMARY:COVID-19 Testing Toolkit Webinar: University Testing Strategies
DESCRIPTION:Join the Johns Hopkins Center for Health Security’s COVID-19 Testing Toolkit for a webinar where panelists will discuss how Johns Hopkins University developed and implemented its COVID-19 testing strategies for faculty\, staff\, and students \nMODERATOR \nGigi Gronvall\, PhD\, Senior Scholar\, Johns Hopkins Center for Health Security; Lead\, COVID-19 Testing Toolkit and Associate Professor in the Department of Environmental Health and Engineering at the Johns Hopkins Bloomberg School of Public Health \nPANELISTS \nStephen Gange\, PhD\, Professor of Epidemiology in the Johns Hopkins Bloomberg School of Public Health with a joint appointment in the School of Medicine\, and Executive Vice Provost for Academic Affairs\, Johns Hopkins University \nJonathan Links\, PhD\, Professor of Environmental Health and Engineering in the Johns Hopkins Bloomberg School of Public Health \, with joint professorial appointments in the schools of Medicine\, Education\, Engineering\, and Business\, and Vice Provost and Chief Risk Officer\, Johns Hopkins University \nLainie Rutkow\, JD\, PhD\, Professor of Health Policy and Management in the Johns Hopkins Bloomberg School of Public Health with a joint appointment in the School of Medicine\, and Vice Provost for Interdisciplinary Initiatives\, Johns Hopkins University. \nThe moderated discussion will be followed by a Q&A session. Media are invited. \nLearn more about this event and register HERE.
URL:https://globalbiodefense.com/event/covid-19-testing-toolkit-webinar-university-testing-strategies/
CATEGORIES:Conference,Webinar-Webcast
LOCATION:https://jh.zoom.us/webinar/register/WN_I19cGA6FSNWGPHt_6xaYCA
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20220504T120000
DTEND;TZID=America/New_York:20220504T133000
DTSTAMP:20220422T200622Z
CREATED:20220422T195642Z
LAST-MODIFIED:20220422T200622Z
UID:54839-1651665600-1651671000@globalbiodefense.com
SUMMARY:Biological Risks and Hazards in the World Today - Special Focus on Russia and Ukraine
DESCRIPTION:An expert panel on Biological Risks and Hazards in the World Today with a Special Focus on Russia and Ukraine will be held on 4 May 2022 via webcast. \nTopics will include the health security environment in the post-Soviet states\, as assessed by the Global Health Security Index of 2019 and 2021\, and the biological risks posed by Russia’s invasion of Ukraine and associated disinformation campaign. \nJessica Bell and Hayley Secerance\, of the Nuclear Threat Initiative\, will discuss health security environment across the post-Soviet states. \nGregory Koblentz of George Mason University will address the evolving biosecurity landscape. \nHon. Andrew Weber of the Council on Strategic Risks and former Assistant Secretary of Defense for the Obama Administration will discuss what we know and what we don’t know about the Russian Federation’s biological and chemical weapons’ program. \nRebecca Katz of Georgetown University and Ian Lipkin of Columbia University round out the event. \nThe webinar will be moderated by Wilmot James. \nPlease visit the Columbia University Institute for Social and Economic Research and Policy (ISERP) Biological Risks and Hazards in the World Today event page to register.
URL:https://globalbiodefense.com/event/iserp-biological-risk-hazards-russia-ukraine/
CATEGORIES:Conference,Webinar-Webcast
LOCATION:https://columbiauniversity.zoom.us/webinar/register/WN_EalzNo1oQw6zWvNG-iWjvA
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20220510
DTEND;VALUE=DATE:20220512
DTSTAMP:20220325T162045Z
CREATED:20220325T162045Z
LAST-MODIFIED:20220325T162045Z
UID:54586-1652140800-1652313599@globalbiodefense.com
SUMMARY:FutureTox V: New Technologies to Evaluate Organ-Specific Effects of Drugs and Chemicals
DESCRIPTION:The Society of Toxicology will host FutureTox V: New Technologies to Evaluate Organ-Specific Effects of Drugs and Chemicals on 10-11 May 2022 in Chapel Hill\, North Carolina. \nThe FutureTox series focuses on building the road for 21st-century toxicology and risk assessment practices\, utilizing in vitro data and in silico models for predictive toxicology\, and taking the high-throughput risk assessment paradigm forward to address challenges in implementing the emerging big-data toolbox for risk assessment and regulatory decision-making. \nHighlighted topics of interest include: \n\nModeling environment for organ-specific computational synthesis and integration\nNovel single cell sequencing-based technologies\nIn silico models of organ-specific effects\nFDA\, EPA discussion on future tech and research needs to evaluate organ-specific effects of drugs and chemicals\nFDA\, EPA discussion on opportunities for regulators to use new models and technologies in evaluating organ-specific effects of drugs and chemicals\nNIEHS/NICEATM\, EPA breakout discussion of ‘big data’ stream utilization in toxicology and risk assessment\nAdvantages and barriers to application of new models for evaluating effects of drugs and chemicals on the blood-brain barrier\nPerfused microphysiological systems\nLiver spheroids and micropatterned cultures\nModeling the gut microbiome\nAir-liquid interface models for airway safety assessment\nOpportunities to advance IVIVE with physiological organ-specific models\n\nPlease visit the Society of Toxicology’s FutureTox V website for more information. \n 
URL:https://globalbiodefense.com/event/futuretox-v-new-technologies-to-evaluate-organ-specific-effects-of-drugs-and-chemicals/
LOCATION:UNC Chapel Hill Friday Center\, 100 Friday Center Drive\, Chapel Hill\, NC\, 27599\, United States
CATEGORIES:Conference
END:VEVENT
END:VCALENDAR